Penetration of Colistin into Cerebrospinal Fluid
- 1 November 2009
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 53 (11), 4907-4910
- https://doi.org/10.1128/aac.00345-09
Abstract
Colistin penetration into the cerebrospinal fluid (CSF) was studied in five critically ill adult patients receiving colistin methanesulfonate for infections by multiresistant gram-negative bacilli. Colistin concentrations were determined in paired serum and CSF samples, with the latter taken by lumbar puncture, with the exception of one patient with an external ventriculostomy. CSF-to-serum ratios (0.051 to 0.057) for all study patients coincided at all sampling times. The low level (5%) of penetration suggests inadequate bactericidal colistin concentrations in the CSF.Keywords
This publication has 17 references indexed in Scilit:
- Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled studyClinical Therapeutics, 2008
- Cure of post-traumatic recurrent multiresistant Gram-negative rod meningitis with intraventricular colistinJournal of Infection, 2005
- Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial InfectionsClinical Infectious Diseases, 2005
- Successful treatment of Acinetobacter meningitis with intrathecal polymyxin EJournal of Antimicrobial Chemotherapy, 2004
- Cerebrospinal Fluid Penetration and Pharmacokinetic/Pharmacodynamic Parameters of Intravenously Administered Colistin in a Case of Multidrug-Resistant Acinetobacter baumannii MeningitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2002
- Considerations in the Use of Cerebrospinal Fluid Pharmacokinetics to Predict Brain Target Concentrations in the Clinical SettingClinical Pharmacokinetics, 2002
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- Successful Treatment of Ventriculitis Due to Carbapenem‐ResistantAcinetobacter baumanniiwith Intraventricular Colistin Sulfomethate SodiumClinical Infectious Diseases, 1999
- Pharmacokinetic Optimisation of the Treatment of Bacterial Central Nervous System InfectionsClinical Pharmacokinetics, 1998
- Antimicrobial Agents and the Central Nervous SystemNeurosurgery, 1980